vs

Side-by-side financial comparison of Amer Sports, Inc. (AS) and MAXIMUS, INC. (MMS). Click either name above to swap in a different company.

MAXIMUS, INC. is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.3× Amer Sports, Inc.). MAXIMUS, INC. runs the higher net margin — 7.0% vs 1.8%, a 5.2% gap on every dollar of revenue. Amer Sports, Inc. produced more free cash flow last quarter ($92.2M vs $-250.7M).

Amer Sports, Inc. is a Finnish multinational sporting equipment division based in Helsinki, Finland. Established in 1950 as an industrial conglomerate with interests as diverse as tobacco trading, ship owning and publishing, Amer has gradually evolved into a multinational firm devoted to the production and marketing of sporting goods. The company employs over 9,700 people. Since 2018, Amer has been a subsidiary of Chinese retail conglomerate Anta Sports.

Maximus Inc. is an American government services company, with operations in countries including the United States, Canada, and the United Kingdom. Maximus provides administration and other services for Medicaid, Medicare, health care reform, welfare-to-work, and student loan servicing, among other government programs. The company is based in Tysons, Virginia, has 39,600 employees and a reported annual revenue of $5.3 billion in fiscal year 2024.

AS vs MMS — Head-to-Head

Bigger by revenue
MMS
MMS
1.3× larger
MMS
$1.3B
$1.1B
AS
Higher net margin
MMS
MMS
5.2% more per $
MMS
7.0%
1.8%
AS
More free cash flow
AS
AS
$342.9M more FCF
AS
$92.2M
$-250.7M
MMS

Income Statement — Q1 FY2024 vs Q1 FY2026

Metric
AS
AS
MMS
MMS
Revenue
$1.1B
$1.3B
Net Profit
$19.0M
$93.9M
Gross Margin
52.8%
23.7%
Operating Margin
12.4%
10.9%
Net Margin
1.8%
7.0%
Revenue YoY
-4.1%
Net Profit YoY
128.0%
EPS (diluted)
$0.05
$1.70

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AS
AS
MMS
MMS
Q4 25
$1.3B
Q3 25
$1.3B
Q2 25
$1.3B
Q1 25
$1.4B
Q4 24
$1.4B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.1B
$1.3B
Net Profit
AS
AS
MMS
MMS
Q4 25
$93.9M
Q3 25
$75.3M
Q2 25
$106.0M
Q1 25
$96.6M
Q4 24
$41.2M
Q3 24
$72.5M
Q2 24
$89.8M
Q1 24
$19.0M
$80.5M
Gross Margin
AS
AS
MMS
MMS
Q4 25
23.7%
Q3 25
25.3%
Q2 25
26.7%
Q1 25
24.9%
Q4 24
21.5%
Q3 24
22.9%
Q2 24
25.3%
Q1 24
52.8%
23.6%
Operating Margin
AS
AS
MMS
MMS
Q4 25
10.9%
Q3 25
9.3%
Q2 25
12.3%
Q1 25
11.2%
Q4 24
6.2%
Q3 24
8.5%
Q2 24
10.8%
Q1 24
12.4%
9.5%
Net Margin
AS
AS
MMS
MMS
Q4 25
7.0%
Q3 25
5.7%
Q2 25
7.9%
Q1 25
7.1%
Q4 24
2.9%
Q3 24
5.5%
Q2 24
6.8%
Q1 24
1.8%
6.0%
EPS (diluted)
AS
AS
MMS
MMS
Q4 25
$1.70
Q3 25
$1.27
Q2 25
$1.86
Q1 25
$1.69
Q4 24
$0.69
Q3 24
$1.18
Q2 24
$1.46
Q1 24
$0.05
$1.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AS
AS
MMS
MMS
Cash + ST InvestmentsLiquidity on hand
$137.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.7B
Total Assets
$4.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AS
AS
MMS
MMS
Q4 25
$137.6M
Q3 25
$222.4M
Q2 25
$59.8M
Q1 25
$108.1M
Q4 24
$72.7M
Q3 24
$183.1M
Q2 24
$102.8M
Q1 24
$77.4M
Stockholders' Equity
AS
AS
MMS
MMS
Q4 25
$1.7B
Q3 25
$1.7B
Q2 25
$1.8B
Q1 25
$1.7B
Q4 24
$1.6B
Q3 24
$1.8B
Q2 24
$1.8B
Q1 24
$1.8B
Total Assets
AS
AS
MMS
MMS
Q4 25
$4.2B
Q3 25
$4.1B
Q2 25
$4.5B
Q1 25
$4.2B
Q4 24
$4.1B
Q3 24
$4.1B
Q2 24
$4.0B
Q1 24
$4.0B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AS
AS
MMS
MMS
Operating Cash FlowLast quarter
$114.3M
$-244.4M
Free Cash FlowOCF − Capex
$92.2M
$-250.7M
FCF MarginFCF / Revenue
8.8%
-18.6%
Capex IntensityCapex / Revenue
2.1%
0.5%
Cash ConversionOCF / Net Profit
6.02×
-2.60×
TTM Free Cash FlowTrailing 4 quarters
$218.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AS
AS
MMS
MMS
Q4 25
$-244.4M
Q3 25
$649.4M
Q2 25
$-182.7M
Q1 25
$42.7M
Q4 24
$-80.0M
Q3 24
$163.8M
Q2 24
$199.3M
Q1 24
$114.3M
$130.5M
Free Cash Flow
AS
AS
MMS
MMS
Q4 25
$-250.7M
Q3 25
$641.8M
Q2 25
$-198.2M
Q1 25
$25.5M
Q4 24
$-103.0M
Q3 24
$131.9M
Q2 24
$164.6M
Q1 24
$92.2M
$105.2M
FCF Margin
AS
AS
MMS
MMS
Q4 25
-18.6%
Q3 25
48.7%
Q2 25
-14.7%
Q1 25
1.9%
Q4 24
-7.3%
Q3 24
10.0%
Q2 24
12.5%
Q1 24
8.8%
7.8%
Capex Intensity
AS
AS
MMS
MMS
Q4 25
0.5%
Q3 25
0.6%
Q2 25
1.1%
Q1 25
1.3%
Q4 24
1.6%
Q3 24
2.4%
Q2 24
2.6%
Q1 24
2.1%
1.9%
Cash Conversion
AS
AS
MMS
MMS
Q4 25
-2.60×
Q3 25
8.63×
Q2 25
-1.72×
Q1 25
0.44×
Q4 24
-1.94×
Q3 24
2.26×
Q2 24
2.22×
Q1 24
6.02×
1.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AS
AS

Americas2$409.6M39%
EMEA1$356.9M34%
Greater China3$205.6M20%
Asia Pacific4$78.2M7%

MMS
MMS

Clinical Services$523.7M39%
Cost Plus Contracts$386.4M29%
Outside The United States$143.2M11%
International Government Agencies$141.0M10%
Technology Solutions$74.8M6%
Employment And Other$70.2M5%
Other Including Local Municipalities And Commercial Customers$17.6M1%

Related Comparisons